QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS PROVIRUS AND CIRCULATING VIRUS - RELATIONSHIP WITH IMMUNOLOGICAL PARAMETERS

被引:52
作者
YERLY, S
CHAMOT, E
HIRSCHEL, B
PERRIN, LH
机构
[1] GENEVA UNIV HOSP, CENT LAB VIROL, CH-1211 GENEVA 4, SWITZERLAND
[2] GENEVA UNIV HOSP, DIV INFECT DIS, CH-1211 GENEVA 4, SWITZERLAND
[3] GENEVA UNIV HOSP, MED OUTPATIENT CLIN, CH-1211 GENEVA, SWITZERLAND
关键词
D O I
10.1093/infdis/166.2.269
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Virologic and seroimmunologic parameters were determined in 56 persons infected with human immunodeficiency virus (HIV). The provirus level varied from 10 to 100,000/10(6) CD4+ lymphocytes, and genomic HIV RNA was detectable in 39 of 56 patients at a relative concentration varying from 10 to >250 copies/mL of serum. Provirus expressed as copies per 10(6) CD4+ lymphocytes and as circulating virus per milliliter of serum increased with disease progression and decrease of CD4+ cell concentration. The mean provirus concentration expressed per milliliter of blood varied little among categories of patients with various levels of CD4+ cells, but there was a progressive increase of circulating HIV genomic RNA. These virologic data suggest that during the course of HIV infection, an increasing proportion of the remaining CD4+ lymphocytes harbor the HIV genome and produce infectious virus. Finally, there was a marked correlation between increased provirus and genomic RNA concentration and three seroimmunologic markers: decrease in CD4+ cell count, p24 antigenemia, and disappearance of antibodies to HIV core antigen.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 25 条
[1]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[2]   EFFICIENT ISOLATION OF HIV FROM PLASMA DURING DIFFERENT STAGES OF HIV INFECTION [J].
EHRNST, A ;
SONNERBORG, A ;
BERGDAHL, S ;
STRANNEGARD, O .
JOURNAL OF MEDICAL VIROLOGY, 1988, 26 (01) :23-32
[3]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[4]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[5]   BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A CLONED LEU-3- CELL SURVIVING INFECTION WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME RETROVIRUS [J].
FOLKS, TM ;
POWELL, D ;
LIGHTFOOTE, M ;
KOENIG, S ;
FAUCI, AS ;
BENN, S ;
RABSON, A ;
DAUGHERTY, D ;
GENDELMAN, HE ;
HOGGAN, MD ;
VENKATESAN, S ;
MARTIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :280-290
[6]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625
[7]   DETECTION AND QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN PATIENT SERUM BY USE OF THE POLYMERASE CHAIN-REACTION [J].
HOLODNIY, M ;
KATZENSTEIN, DA ;
SENGUPTA, S ;
WANG, AM ;
CASIPIT, C ;
SCHWARTZ, DH ;
KONRAD, M ;
GROVES, E ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :862-866
[8]   RAPID AND SENSITIVE VIRAL CULTURE METHOD FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
JACKSON, JB ;
COOMBS, RW ;
SANNERUD, K ;
RHAME, FS ;
BALFOUR, HH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (07) :1416-1418
[9]   SERUM BETA-2-MICROGLOBULIN DECREASES IN PATIENTS WITH AIDS OR ARC TREATED WITH AZIDOTHYMIDINE [J].
JACOBSON, MA ;
ABRAMS, DI ;
VOLBERDING, PA ;
BACCHETTI, P ;
WILBER, J ;
CHAISSON, RE ;
CROWE, S ;
HOWARD, W ;
MOSS, A .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (06) :1029-1036
[10]   QUANTITATION OF HIV-1 PROVIRAL DNA RELATIVE TO CELLULAR DNA BY THE POLYMERASE CHAIN-REACTION [J].
KELLOGG, DE ;
SNINSKY, JJ ;
KWOK, S .
ANALYTICAL BIOCHEMISTRY, 1990, 189 (02) :202-208